Kyowa Hakko Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Neopharm Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Oncolytics Biotech Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Onyvax Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Seattle Genetics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Spectrum Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Supergen Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Synta Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Telik Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Therion Biologics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Topotarget Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Transgene Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Vernalis Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Vical Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Vion Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

ViRexx Medical Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005